Abstract: An artificial blood vessel includes a tubular woven fabric composed of a multifilament yarn A including a first polyester and a multifilament yarn B including a second polyester, and has an inner diameter of 8 mm or less and a layer thickness of 50 ?m or more and 250 ?m or less, wherein the multifilament yarn A has a single fiber fineness of 1.0 dtex or more and a total fineness of 33 dtex or less, the multifilament yarn B has a single fiber fineness of 0.08 dtex or less and a total fineness of 66 dtex or less, and the multifilament yarn B forms loops on an inner wall surface of the tubular woven fabric.

Abstract: An instrument captures free thrombi by inhibiting blood coagulation reaction at the stage of primary hemostasis, in which platelets are involved, and at the stage of coagulation thrombus formation, in which blood coagulation factors are involved, thereby securely capturing free thrombi and extending the available time of the instrument.

Abstract: A hydrophobic polymer compound is capable of inhibiting the blood coagulation reactions in both the primary hemostasis stage involving platelets and the coagulation thrombus formation stage involving blood coagulation factors, which hydrophobic polymer compound can be firmly immobilized on the surface of a medical device or medical material in a state where the compound retains its anticoagulant activity. A hydrophobic polymer compound in which a polymer compound inhibiting platelet adhesion is bound with a compound inhibiting blood coagulation reaction.

Abstract: A medical material has a compound firmly immobilized on the surface thereof, which compound is capable of inhibiting both of the blood coagulation reactions in a primary hemostasis stage in which platelets are involved and in a coagulation thrombus formation stage in which blood coagulation factors are involved in a state retaining the anticoagulant activity. The present invention provides a medical material having a hydrophilic polymer compound immobilized on the surface thereof, in which a compound and a copolymer of monomers selected from the group consisting of ethylene glycol, vinyl acetate, vinyl pyrrolidone, propylene glycol, vinyl alcohol and siloxane are bound.

Abstract: A toner for developing electrostatic latent images, including a binder resin; a colorant; and a release agent, wherein the toner has a glass transition temperature (Tg) of from 55 to 75° C., a melting point (T1/2) of from 95 to 125° C. as measured by a flow tester in a ½ method, and ?Ts of from 1 to 5° C., and wherein ?Ts is defined by the following formula: ?Ts=Ts?T(Ls/2) wherein Ts is a softening point of the toner; T(Ls/2) is a temperature when a stroke is Ls/2; and Ls is a stroke (mm) at Ts.

Abstract: A hydrophilic polymer compound includes a polymer compound which inhibits platelet adhesion, and a compound that inhibits blood coagulation reaction, bound to the polymer compound.

Abstract: A toner for developing electrostatic latent images, including a binder resin; a colorant; and a release agent, wherein the toner has a glass transition temperature (Tg) of from 55 to 75° C., a melting point (T1/2) of from 95 to 125° C. as measured by a flow tester in a ½ method, and ?Ts of from 1 to 5° C., and wherein ?Ts is defined by the following formula: ?Ts=Ts?T(Ls/2) wherein Ts is a softening point of the toner; T(Ls/2) is a temperature when a stroke is Ls/2; and Ls is a stroke (mm) at Ts.